News search

Keyword

Locations

News type

Sectors

Services

Transformations

Life Sciences and Healthcare

Osborne Clarke advises WG Partners on £27.7 million Redx Pharma fundraising

02/12/2020

• 1 min

Corporate

Osborne Clarke supports Kartesia on second UK deal in two weeks

01/12/2020

• 1 min

Intellectual property

Life Sciences Patent litigator Tim Harris joins Osborne Clarke

30/11/2020

• 1 min

Tech, Media and Comms

Osborne Clarke advises Mirriad Advertising on £23M equity fundraising

30/11/2020

• 1 min

Corporate

Osborne Clarke advises CTS on Sprout IT acquisition

27/11/2020

• 1 min

Osborne Clarke appoints Peter Day as its new London location head

25/11/2020

• 2 mins

Corporate

Osborne Clarke advises Synova Capital on MBO of insurance specialist JM Glendinning

23/11/2020

• 1 min

Legal Notice

When you read about Osborne Clarke on this site, we are either referring to our international organisation, Osborne Clarke Verein (OCV), or one of its member firms. OCV is a Swiss verein and doesn’t provide services to clients. The OCV member firms are all separate legal entities and have no authority to obligate or bind each other or OCV with regard to third parties. To find out more, click here.

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

News search

Osborne Clarke advises WG Partners on £27.7 million Redx Pharma fundraising

Osborne Clarke supports Kartesia on second UK deal in two weeks

Life Sciences Patent litigator Tim Harris joins Osborne Clarke

Osborne Clarke advises Mirriad Advertising on £23M equity fundraising

Osborne Clarke advises CTS on Sprout IT acquisition

Osborne Clarke appoints Peter Day as its new London location head

Osborne Clarke advises Warburg Pincus in McMakler Series C2 financing round

Osborne Clarke advises Synova Capital on MBO of insurance specialist JM Glendinning

Sign up for our newsletter

Legal Notice